RRC ID 18936
Author Nakajima K, Komiyama Y, Hojo H, Ohba S, Yano F, Nishikawa N, Ihara S, Aburatani H, Takato T, Chung UI.
Title Enhancement of bone formation ex vivo and in vivo by a helioxanthin-derivative.
Journal Biochem Biophys Res Commun
Abstract To effectively treat serious bone defects using bone-regenerative medicine, a small chemical compound that potently induces bone formation must be developed. We previously reported on the osteogenic effect of 4-(4-methoxyphenyl)pyrido[40,30:4,5]thieno[2,3-b]pyridine-2-carboxamide (TH), a helioxanthin-derivative, in vitro. Here, we report on TH's osteogenic effects ex vivo and in vivo. TH-induced new bone formation in both calvarial and metatarsal organ cultures. A novel monitoring system of osteoblastic differentiation using MC3T3-E1 cells revealed that TH was released from alpha-TCP bone cement and this release continued for more than one month. Lastly, the implantation of the alpha-TCP carrier containing TH into defects in mouse skull resulted in increased new bone areas within the defects after 4 weeks. A TH-containing scaffold may help establish a more efficient bone regeneration system.
Volume 395(4)
Pages 502-8
Published 2010-5-14
DOI 10.1016/j.bbrc.2010.04.041
PII S0006-291X(10)00703-5
PMID 20382113
MeSH 3T3 Cells Animals Bone Regeneration* Lignans / pharmacology* Metatarsus Mice Organ Culture Techniques Osteoblasts / drug effects* Osteogenesis / drug effects* Pyridines / pharmacology* Skull Thienopyridines Thiophenes / pharmacology*
IF 2.985
Times Cited 9
WOS Category BIOPHYSICS BIOCHEMISTRY & MOLECULAR BIOLOGY
Resource
Human and Animal Cells MC3T3-E1(RCB1126)